We are live on
!
Find out more
VanEck Associates Portfolio holdings
AUM
$133B
1-Year Est. Return
72.99%
This Fund
S&P 500
This Quarter
Est. Return
+2.23%
1 Year Est. Return
+72.99%
3 Year Est. Return
+157.94%
5 Year Est. Return
+206.35%
10 Year Est. Return
+770.56%
AUM
$36.8B
AUM Growth
+$2.43B
(+7.1%)
Cap. Flow
+$2.77B
Cap. Flow
% of AUM
7.53%
Top 10 Holdings %
Top 10 Hldgs %
28.22%
Holding
1,252
New
233
Increased
711
Reduced
271
Closed
25
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TSMC
TSM
|
+$318M |
| 2 |
NVIDIA
NVDA
|
+$202M |
| 3 |
Advanced Micro Devices
AMD
|
+$138M |
| 4 |
Intel
INTC
|
+$138M |
| 5 |
Qualcomm
QCOM
|
+$134M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
KL
Kirkland Lake Gold Ltd Ordinary
KL
|
+$162M |
| 2 |
AngloGold Ashanti
AU
|
+$111M |
| 3 |
Kinross Gold
KGC
|
+$94.2M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$74.5M |
| 5 |
Royal Gold
RGLD
|
+$69.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Materials | 43.39% |
| 2 | Technology | 21.08% |
| 3 | Healthcare | 6.17% |
| 4 | Energy | 5.2% |
| 5 | Financials | 4.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Honeywell
HON
$78.2B
| $14.6M | 0.04% |
71,230
+1,623
| +2% | +$317K |
|
277
Bausch Health
BHC
$2.62B
| $14.5M | 0.04% |
458,249
+94,057
| +26% | +$2.76M |
|
278
CRISPR Therapeutics
CRSP
$4.88B
| $14.5M | 0.04% |
+119,081
| New | +$18M |
|
279
Oaktree Specialty Lending
OCSL
$1.05B
| $14.4M | 0.04% |
776,198
+133,625
| +21% | +$2.4M |
|
280
BioNTech
BNTX
$23.3B
| $14.4M | 0.04% |
131,691
-24,763
| -16% | -$2.63M |
|
281
DMC Global
BOOM
$149M
| $14.3M | 0.04% |
263,793
+19,767
| +8% | +$1.13M |
|
282
VanEck Intermediate Muni ETF
ITM
$2.14B
| $14.3M | 0.04% |
279,116
+6
| +0% | +$310 |
|
|
GLDG
283
GoldMining Inc
GLDG
$190M
| $14.2M | 0.04% |
8,603,486
-366,638
| -4% | -$654K |
|
284
Duke Energy
DUK
$96.9B
| $14.2M | 0.04% |
146,925
+9,289
| +7% | +$848K |
|
285
Alnylam Pharmaceuticals
ALNY
$29.5B
| $14.2M | 0.04% |
100,254
-4,975
| -5% | -$749K |
|
286
American Tower
AMT
$80.6B
| $14.1M | 0.04% |
59,084
+7,973
| +16% | +$1.78M |
|
287
Nike
NKE
$63.3B
| $14.1M | 0.04% |
105,748
+5,491
| +5% | +$763K |
|
|
DTP
288
DELISTED
DTE Energy Company 2019 Corporate Units
DTP
| $14M | 0.04% |
281,618
+25,530
| +10% | +$1.22M |
|
289
BioMarin Pharmaceuticals
BMRN
$11.6B
| $13.8M | 0.04% |
182,320
-10,693
| -6% | -$873K |
|
|
GFLU
290
DELISTED
GFL Environmental Inc. Tangible Equity Units
GFLU
| $13.7M | 0.04% |
167,883
+15,215
| +10% | +$1.12M |
|
291
Nuveen AMT-Free Municipal Credit Income Fund
NVG
$2.66B
| $13.6M | 0.04% |
806,093
+48,082
| +6% | +$803K |
|
292
Cencora
COR
$60B
| $13.6M | 0.04% |
115,339
-21,906
| -16% | -$2.37M |
|
293
Carlyle Secured Lending
CGBD
$713M
| $13.6M | 0.04% |
1,028,504
+133,086
| +15% | +$1.61M |
|
294
Nuveen Quality Municipal Income Fund
NAD
$2.73B
| $13.6M | 0.04% |
896,684
+61,398
| +7% | +$926K |
|
295
Nuveen AMT-Free Quality Municipal Income Fund
NEA
$3.37B
| $13.6M | 0.04% |
914,531
+70,756
| +8% | +$1.05M |
|
|
CIM
296
Chimera Investment
CIM
$1.06B
| $13.4M | 0.04% |
351,231
-24,276
| -6% | -$829K |
|
297
CVS Health
CVS
$134B
| $13.3M | 0.04% |
177,315
+31,929
| +22% | +$2.33M |
|
298
Enbridge
ENB
$118B
| $13.3M | 0.04% |
365,925
+8,468
| +2% | +$298K |
|
|
MMX
299
DELISTED
Maverix Metals Inc. Common Shares
MMX
| $13.2M | 0.04% |
2,513,158
+2,512,087
| +234,555% | +$13.3M |
|
300
Eli Lilly
LLY
$1,000B
| $13.2M | 0.04% |
70,484
-23,116
| -25% | -$4.52M |
|
Similar funds
VanEck Associates's Q1 2021 Portfolio in Review
As of Q1 2021, VanEck Associates held 1,252 positions worth $36.8B, up 7.1% from $34.3B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
VanEck Associates deployed $2.77B of net new capital in Q1 2021, opening 233 new positions and adding to 711 existing holdings. Its largest new stake was Tyler Technologies: 171,772 shares worth $72.9M.
By sector, the portfolio is most concentrated in Materials at 43% of assets, down from 53% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Kirkland Lake Gold Ltd Ordinary, an estimated $162M trimmed.
- VanEck Associates's largest Q1 2021 buy was Tyler Technologies: 171,772 shares worth $72.9M.
- VanEck Associates added most to TSMC in Q1 2021, an estimated $318M increase.
- VanEck Associates's biggest Q1 2021 reduction was Kirkland Lake Gold Ltd Ordinary, cutting an estimated $162M.
- VanEck Associates fully exited Tiffany & Co. in Q1 2021, selling an estimated $55.3M.
- VanEck Associates's ten largest holdings make up 28% of its $36.8B portfolio in Q1 2021.
- VanEck Associates opened 233 new positions and closed 25 in Q1 2021.
- VanEck Associates's portfolio value rose 7.1% quarter-over-quarter to $36.8B.
Based on VanEck Associates's 13F filing for Q1 2021, filed 13 May 2021.